Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Arcila
    Arcila
  3. Berger
    Berger
  4. Nafa
    Nafa
  5. Hakimi
    Hakimi
  6. D'Angelica
    D'Angelica
  7. Jarnagin
    Jarnagin
  8. Kingham
    Kingham
  9. Solit
    Solit
  10. Russo
    Russo

Groups

  1. Human Oncology and Pathogenesis Program (249)
  2. GSK Faculty (221)
  3. Department of Pathology and Laboratory Medicine (166)
  4. Tow Center for Developmental Oncology (TCDO) (134)
  5. Department of Medicine (108)
  6. Surgery (100)
  7. Solid Tumor Oncology Division (85)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (61)
  9. Sloan Kettering Institute Postdocs (59)
  10. Center for Pancreatic Cancer Research (55)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (131)
  2. Meeting Abstract (103)
  3. Review (9)
  4. Correspondence (4)
  5. Editorial (2)
Groups
  1. Human Oncology and Pathogenesis Program (249)
  2. GSK Faculty (221)
  3. Department of Pathology and Laboratory Medicine (166)
  4. Tow Center for Developmental Oncology (TCDO) (134)
  5. Department of Medicine (108)
  6. Surgery (100)

More Groups

People
  1. Marc Ladanyi (120)
  2. Maria Arcila (65)
  3. Michael Berger (46)
  4. Khedoudja Nafa (44)
  5. Ahmet Zehir (43)
  6. Abraham Hakimi (41)

More People

Years
  1. 2025 (5)
  2. 2024 (12)
  3. 2023 (14)
  4. 2022 (14)
  5. 2021 (14)
  6. 2020 (19)

More Years

Publications
  1. Journal of Molecular Diagnostics (108)
  2. European Urology (31)
  3. Journal of Urology (17)
  4. Journal of the American College of Surgeons (17)
  5. American Journal of Pathology (16)
  6. Lancet Oncology (15)

More Publications

Results (249)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Blay, J. Y.; Serrano, C.; Heinrich, M. C.; Zalcberg, J.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Histopathological growth patterns and positive margins after resection of colorectal liver metastases
    Journal Article

    Nierop, P. M. H.; Höppener, D. J.; van der Stok, E. P.; Galjart, B.; Buisman, F. E.; Balachandran, V. P.; Jarnagin, W. R.; Kingham, T. P.; Allen, P. J.; Shia, J.; more...
    HPB (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Larotrectinib in patients with TRK fusion-positive solid tumours: A pooled analysis of three phase 1/2 clinical trials
    Journal Article

    Hong, D. S.; DuBois, S. G.; Kummar, S.; Farago, A. F.; Albert, C. M.; Rohrberg, K. S.; van Tilburg, C. M.; Nagasubramanian, R.; Berlin, J. D.; Federman, N.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Reliable clinical MLH1 promoter hypermethylation assessment using a high-throughput genome-wide methylation array platform
    Journal Article

    Benhamida, J. K.; Hechtman, J. F.; Nafa, K.; Villafania, L.; Sadowska, J.; Wang, J.; Wong, D.; Zehir, A.; Zhang, L.; Bale, T.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • The role of cytoreductive nephrectomy for sarcomatoid renal cell carcinoma: A 29-year institutional experience
    Journal Article

    Silagy, A. W.; Mano, R.; Blum, K. A.; DiNatale, R. G.; Marcon, J.; Tickoo, S. K.; Reznik, E.; Coleman, J. A.; Russo, P.; Hakimi, A. A.
    Urology (2020)

    Fulltext@MSK | Save
  • Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: A cohort study
    Journal Article

    Sanchez, A.; Furberg, H.; Kuo, F.; Vuong, L.; Ged, Y.; Patil, S.; Ostrovnaya, I.; Petruzella, S.; Reising, A.; Patel, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: A retrospective cohort study
    Journal Article

    Petersdorf, E. W.; Carrington, M.; O'hUigin, C.; Bengtsson, M.; De Santis, D.; Dubois, V.; Gooley, T.; Horowitz, M.; Hsu, K.; Madrigal, J. A.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Validation and implementation of ultra-rapid mutation and MSI assessment using the Idylla platform
    Meeting Abstract

    Nafa, K.; Momeni Boroujeni, A.; Gandia, E.; Solomon, J. P.; Vakiani, E.; Zhu, M.; Chan, R.; Elezovic, D.; Mensah, N. T.; Rijo, I.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save